학술논문

Phase II study of a trastuzumab biosimilar in combination with paclitaxel for HER2-positive recurrent or metastatic urothelial carcinoma: KCSG GU18-18
Document Type
Article
Source
In ESMO Open August 2023 8(4)
Subject
Genitourinary Cancers
Language
ISSN
2059-7029